What You Should Know: - Medtronic announced the U.S. launch of Medtronic Extended infusion set, the first and only infusion set labeled for up to 7-day wear. An infusion set is tubing that delivers insulin from an insulin pump to the body and typically requires a set change every two to three days. - The Medtronic Extended infusion set uses advanced materials that help reduce insulin preservative loss and maintain insulin flow and stability to double the wear time of an infusion set. The
Read More
HLTH22: Henry Schein Medical Expands SolutionsHub with Rimidi
What You Should Know: - Henry Schein Medical today announced the expansion of its Solutions Hub with Rimidi, a SaaS company that brings together remote patient monitoring, patient-reported outcomes, and clinical decision support to help enhance patient care. - With this partnership, clinics, medical groups, and health systems served by Henry Schein will have access to Rimidi’s cloud-based software platform, which helps deliver an efficient model of care for patients with chronic
Read More
Ascensia Launches Diabetes Management and Analytics Platform in the U.S
What You Should Know: - Ascensia Diabetes Care, a global diabetes care company, maker of the CONTOUR® blood glucose monitoring (BGM) system portfolio and exclusive distributor of Eversense® Continuous Glucose Monitoring (CGM) Systems, has launched its online diabetes management and analytics platform GlucoContro.online in the United States. - Now available in more than 15 countries globally and in the process of further expansion, GlucoContro.online support diabetes management by
Read More
Medical Devices Cleared or Approved by FDA in 2022
The medical device industry is booming and shows no signs of slowing down. In 2022, the FDA (Federal Food and Drug Administration) will clear or approve over 1,000 medical devices. This is great news for patients who stand to benefit from the latest and greatest technology, but it can be tough for hospitals and doctors to keep up with all of the new devices on the market. Here's a breakdown of some of the most anticipated otc medical devices that have already received FDA approval. Some
Read More
Glytec and CPS Integrate to Provide Evidence-Based Glycemic Management
What You Should Know: - Glytec recently announced that it has been selected by CPS Solutions, LLC (CPS), a leading provider of enterprise pharmacy solutions to hospitals and health systems, to serve as an insulin management technology resource for CPS’ more than 2,200 pharmacy professionals across 800-plus healthcare facilities nationwide. - Through this collaboration, CPS client facilities may contract for Glytec’s eGlycemic Management System® (eGMS) and Glytec’s technical resources to be
Read More
Healthcare Companies on the Stock Market
Good healthcare and the financial sector cannot be separated entirely, even when their base motivations lie in different directions. While the medical sector should focus more on the health of the patients instead of consumerism, a good amount of capital is needed to ensure a functional system. Naturally, we can find healthcare companies on the stock market. Considering the continuous need for health care, that is not tied to market crashes the way other stocks are, this is a great chance for
Read More
Glooko Launches Diabetes Medical Education Academy in Ireland
What You Should Know: - Glooko announced, in partnership with the Diabetes Technology Network (DTN)/Association of British Clinical Diabetologists (ABCD), the expansion into Ireland of Academy, the company’s online medical education program for clinicians who treat people with diabetes. - Originally inspired after discussions with the National Health Service England (NHSE) as part of its effort to ensure all healthcare professionals learn uniformly about technology, the program will help
Read More
At-Home Digital Health Innovations Transforming Diabetes Care
If you’re looking for a silver lining in the COVID-19 dark cloud still enshrouding the world, consider this: The pandemic has turbocharged widespread acceptance of at-home digital health solutions. Forced to function in a world of social distancing, healthcare providers and physicians have quickly discovered how easily telehealth visits, remote patient monitoring (RPM) and digital therapeutics can improve patient care. Many of these digital health innovations are designed to address
Read More
Medtronic Secures 2 CE Mark Approvals for Guardian 4 Sensor & For InPen MDI Smart Insulin Pen
What You Should Know: - Today Medtronic announced multiple CE Marks for a portfolio of diabetes products that will launch in Europe later this year. This includes InPen and Guardian 4 sensor which requires no fingersticks - . The new CE Marks also allow for this next generation sensor to be integrated with either MiniMed 780G or InPen or for stand-alone CGM use as well. InPen MDI Smart Insulin Pen The InPen is the first and only smart insulin pen approved in Europe that's
Read More
Glooko Integrates with Eli Lilly’s Connected Insulin Pen Solutions in Global Markets
What We Should Know: - Glooko Inc., a provider of remote patient monitoring and data management solutions for diabetes and other chronic conditions announced a strategic collaboration with Eli Lilly and Company for people with diabetes that use Lilly’s connected insulin pen solutions. - The technology collaboration will ease insulin management for people with diabetes and their healthcare providers in markets outside the U.S., via integration of Lilly’s Tempo Pen™ and
Read More
